SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Long Island Press1d
Guggenheim Elementary guest speaker shares experiences in Africa
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Workday upgraded to Neutral at Guggenheim on reinvigorated growth
As previously reported, Guggenheim analyst John DiFucci upgraded Workday (WDAY) to Neutral from Sell with no price target While the firm still ...
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Time Out17d
All the art exhibits coming to NYC's Guggenheim Museum in 2025
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
Rubrik price target raised to $76 from $72 at Guggenheim
Guggenheim analyst John DiFucci raised the firm’s price target on Rubrik (RBRK) to $76 from $72 and keeps a Buy rating on the shares. The firm ...
Orphism, the early 20th century art movement, in focus at New York’s Guggenheim Museum
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
MongoDB Gains On Buy Call. Why Analyst Is Bullish Software Stock Can Shake Off Slump.
MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.
Morningstar1d
Guggenheim Macro Opportunities A
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...